Borer Denton & Associates, Inc. Abbott Laboratories Transaction History
Borer Denton & Associates, Inc.
- $283 Billion
- Q1 2024
A detailed history of Borer Denton & Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Borer Denton & Associates, Inc. holds 78,593 shares of ABT stock, worth $8.02 Million. This represents 3.16% of its overall portfolio holdings.
Number of Shares
78,593
Previous 78,188
0.52%
Holding current value
$8.02 Million
Previous $8.61 Billion
3.8%
% of portfolio
3.16%
Previous 3.29%
Shares
9 transactions
Others Institutions Holding ABT
# of Institutions
3,118Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.19M-
Vanguard Group Inc Valley Forge, PA165MShares$16.9 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.6 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.57 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.63 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.16 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $179B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...